Inhibikase Therapeutics, Inc. (IKT)

Typically moves ±2.49% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-16 ESTIMATED

Inhibikase Therapeutics, Inc. (IKT) has reported earnings 8 times since Nov 17, 2022. The stock moves an average of ±2.49% the day after reporting, closing higher 37.5% of the time. Its largest post-earnings gain was +3.6% (Nov 17, 2022) and its largest decline was -4.25% (May 14, 2025). The next earnings report is predicted for 2026-11-16 (estimated).

Earnings reactions

How IKT moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±2.49%

Positive %

37.5%

Negative %

62.5%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 11, 2026	☽ POST	-1.84%	open_in_new
May 12, 2026	☽ POST	-0.79%	open_in_new
Mar 26, 2026	☽ POST	+3.07%	open_in_new
Nov 14, 2025	☽ POST	-0.65%	open_in_new
Aug 14, 2025	☽ POST	+2.34%	open_in_new
May 14, 2025	☽ POST	-4.25%	open_in_new
Mar 27, 2025	☽ POST	-3.38%	open_in_new
Nov 17, 2022	☽ POST	+3.6%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±2.49%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 18 →

Funds holding

$36322571

Total value held

Buying

11 added · 5 reduced

Blackrock, Inc.

$15769155 +23.24%

Blackstone Inc.

$12054700 NEW BUY

State Street Corp

$3875475 +13.24%

Northern Trust Corp

$1783527 +22.23%

Bank Of New York Mellon Corp

$615346 +42.17%

SEC Filing Types

description SCHEDULE 13G/A

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
8-K	20260908	open_in_new SEC.gov
8-K	20260826	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260813	open_in_new SEC.gov
10-Q	20260811	open_in_new SEC.gov
8-K	20260811	open_in_new SEC.gov
S-8	20260811	open_in_new SEC.gov
4	20260731	open_in_new SEC.gov
4	20260731	open_in_new SEC.gov

Frequently asked about IKT earnings

When does Inhibikase Therapeutics, Inc. report earnings next? expand_more

Inhibikase Therapeutics, Inc. (IKT)'s next earnings date is estimated for 2026-11-16. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does IKT stock move after earnings? expand_more

Over 8 reports, IKT has moved an average of ±2.49% the session after earnings, closing higher 37.5% of the time.

What was IKT's biggest post-earnings move? expand_more

IKT's largest post-earnings gain on record was +3.6% on Nov 17, 2022, and its largest decline was -4.25% on May 14, 2025.

Where can I find Inhibikase Therapeutics, Inc.'s SEC filings? expand_more

All of Inhibikase Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.